eFoodSafety.com, Inc. (OTCBB:EFSF) is pleased to announce that through its joint-venture partner, CK41 Direct, Inc., celebrities Carmen Electra and Maria Menounos have signed multi-year contracts to promote the company's PurEffect anti-acne product via nationally broadcast direct sales infomercials. Production began July 6, 2007. Under the current production schedule, PurEffect infomercials will begin broadcasting in Fall 2007. The company expects that sales revenue should follow almost immediately.
As announced on March 23, 2006, the company reported that market studies for PurEffect infomercials are estimated to result in revenue of more than "$100 million in gross sales in the first year following the infomercial's national roll-out." Internationally, "sales could easily approach $200 million."
eFoodSafety.com's joint-venture partner, CK41 Direct, Inc., is handling production and all worldwide broadcast and marketing of the product. Christine McDonald, Chairman of the Board of CK41 Direct stated, "We are eager to introduce PurEffect to the market with Ms. Electra and Ms. Menounos as the on-air personality presenters. We have plans to sign more celebrities to our cast shortly as the program unfolds."
"Our market studies confirm that 85% of the 12 to 25 year-old target market, about 17 million young Americans, suffer from acne disfigurement," said McDonald. "We believe that these high-profile celebrity endorsements, along with the clinically proven product effectiveness, will make a powerful case for purchase and use of PurEffect."
CK41 Direct, Inc. is engaged in the marketing, production, and distribution of infomercials. The Board of Directors of CK41 boasts several infomercial successes, such as "Ab Away Pro," "Body by Jake" fitness products, and "Rapid White" tooth whitening system. Other successes include "Krunchmaster Ab System," "Medicus 5 Iron Dual-Hinge Golf Club," and "Laser Perfect 4" to name just a few.
Patricia Gruden, President and CEO of eFoodSafety.com stated, "We have been anticipating this celebrity announcement for some time. We're thrilled to now have the endorsement of two very high-profile personalities for the PurEffect product and eagerly await the announcement of additional celebrity signings."
"This comes at a time when eFoodSafety.com has also been achieving significant progress toward bringing other products to market," Gruden added. "We expect the work we've completed to date will soon bear fruit for all eFoodSafety.com shareholders who have patiently followed the progress of our research and product development efforts."
About Carmen Electra
Carmen Electra is a high-profile celebrity who has significant recognition among a target audience of teens and young adults. In September 2004 she was voted the Sexiest Woman of the Year by FHM Magazine. In addition to modeling for Max Factor as a face model, she has appeared multiple times, including a cover, in Playboy, starred for two seasons on Baywatch, and has had numerous TV and cable program appearances. Her filmography includes popular movies such as the Scary Movie series, Starsky and Hutch, and My Boss's Daughter.
About Maria Menounos
Maria Menounos is an Access Hollywood correspondent with a stellar reputation and stellar beauty. She was a correspondent for Entertainment Tonight. In 1996, she won the title of Miss Massachusetts Teen USA and has been wowing audiences ever since, including at the 2004 Oscars by wearing a diamond-studded dress worth more than $2.5 million. Maria personally awarded Sir Sean Connery the AFI Lifetime Achievement Award along with Harrison Ford, George Lucas and Steven Spielberg. She was recently featured in the March/April, 2007 issue of Hollywood Life magazine and Teen Choice Awards 2006.
About eFoodSafety.com, Inc.
eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin (formerly named Big Six Plus) - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn-CI/bid Scar Cream, that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn line. The Company is also owner of Cinnergen, a clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com) and Cinnechol, a new multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects. The Company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect anti-acne skin care system.
Please visit the Company's website at: http://www.efoodsafety.com.
Safe Harbor Forward-Looking Statements
Statements contained in this release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.
